Donna Shiroma
Net Worth
Last updated:
What is Donna Shiroma net worth?
The estimated net worth of Ms. Donna Shiroma is at least $2,270,779 as of 21 Aug 2023. She owns shares worth $243,105 as insider, has earned $132,834 from insider trading and has received compensation worth at least $1,894,840 in AVITA Medical, Inc. and AVITA Medical, Inc..
What is the salary of Donna Shiroma?
Ms. Donna Shiroma salary is $473,710 per year as Gen. Counsel & Sec. in AVITA Medical, Inc.. She also receives $473,710 as Gen. Counsel & Sec. in AVITA Medical, Inc..
How old is Donna Shiroma?
Ms. Donna Shiroma is 63 years old, born in 1962.
What stocks does Donna Shiroma currently own?
As insider, Ms. Donna Shiroma owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| AVITA Medical, Inc. (RCEL) | Gen. Counsel & Sec. | 42,257 | $4.94 | $208,750 |
| AVITA Medical, Inc. (AVHHL) | Gen. Counsel & Sec. | 42,257 | $0.81 | $34,355 |
What does AVITA Medical, Inc. do?
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
What does AVITA Medical, Inc. do?
AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's skin to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California.
Donna Shiroma insider trading
AVITA Medical, Inc.
Ms. Donna Shiroma has made only one insider trade in 2023, according to the Form 4 filled with the SEC. She sold 4,193 units of RCEL stock worth $66,417 on 21 Aug 2023.
As of 21 Aug 2023 she still owns at least 42,257 units of RCEL stock.
AVITA Medical, Inc.
Ms. Donna Shiroma has made only one insider trade in 2023, according to the Form 4 filled with the SEC. She sold 4,193 units of AVHHL stock worth $66,417 on 21 Aug 2023.
As of 21 Aug 2023 she still owns at least 42,257 units of AVHHL stock.
AVITA Medical key executives
AVITA Medical, Inc. executives and other stock owners filed with the SEC:
- Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D. (66) Chief Executive Officer, Pres & Executive Director
- Mr. Andrew Quick (54) Chief Technology Officer
- Mr. Michael Bria Holder MBA (62) Chief Financial Officer
- Ms. Donna Shiroma (63) Gen. Counsel & Sec.
- Ms. Erin Liberto (51) Chief Commercial Officer
- Ms. Kathy M. McGee (59) Chief Operating Officer